Stereotaxis to Share its Latest Technology Advancements and Clinical Evidence at Cardiostim 2016 in Nice, France June 8-11
June 07, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
Paracelsus Medical University Clinical Study on Stereotaxis Technology Benefits Recognized at European Cardiac Arrhythmia Society Congress
June 01, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 01, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a...
Stereotaxis Reports 2016 First Quarter Financial Results
May 09, 2016 16:05 ET
|
Stereotaxis, Inc.
Ventricular tachycardia procedures increased 27% year over year, representing the third consecutive quarter of 20%+ volume growthFourth Niobe® system shipped to JapanPatient enrollment completed...
Stereotaxis to Highlight New Clinical Results and Automation Enhancements at Heart Rhythm 2016 in San Francisco May 4-7
May 04, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 04, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
Stereotaxis to Report First Quarter 2016 Financial Results on May 9, 2016
May 02, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will release...
Stereotaxis Awarded U.S. Patent for Vmotion Spotlight Automation Feature of Vdrive® Robotic Navigation System
April 29, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 29, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the U.S....
Lund University Hospital Study Validates Improved Long-Term Clinical Outcomes Using Stereotaxis Technology
April 07, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 07, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of a...
U.S. Hospital Surpasses 1,000 Procedures using Stereotaxis Niobe® System
April 04, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 04, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that the Hoffman...
Stereotaxis Completes Patient Enrollment for Niobe® System’s Post-Market Surveillance in Japan
March 30, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 30, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that Takatsuki...
Centre Hospitalier Régional Universitaire de Nancy Strengthens Leadership in Cardiac Rhythm Management through Stereotaxis Technology
March 18, 2016 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 18, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the first...